Allegations of Research Misconduct

MEDICA (International Medical Scientific Journal) is committed to maintaining the highest standards of research integrity, academic honesty, and publication ethics. The journal expects all authors, editors, reviewers, and other parties involved in the publication process to adhere to responsible research practices and established ethical standards. MEDICA does not tolerate research misconduct or any action that compromises the credibility, transparency, or reliability of scholarly publications.

1. Types of Research Misconduct

MEDICA considers the following practices to constitute research misconduct or potential violations of research and publication ethics:

  1. Fabrication: Inventing research data, results, observations, participants, or experimental procedures and presenting them as genuine research findings.

  2. Falsification: Manipulating research materials, equipment, procedures, data, images, or results, or selectively altering or omitting information in a manner that misrepresents the research findings.

  3. Plagiarism: Using another person's ideas, words, data, images, methods, or findings without appropriate acknowledgment, citation, or permission where required.

  4. Duplicate or Redundant Publication: Submitting or publishing substantially similar research in more than one journal or publication without appropriate disclosure, justification, or acknowledgment of the previous publication.

  5. Authorship Misconduct: Inappropriately including individuals who have not made qualifying contributions, excluding legitimate contributors, manipulating author order or affiliations dishonestly, or submitting inaccurate authorship information without proper agreement.

  6. Citation Manipulation: Deliberately including irrelevant references, coercing authors to cite particular publications, or manipulating citations to artificially increase citation counts or journal metrics.

  7. Peer-Review Manipulation: Providing false reviewer identities or contact details, creating fraudulent reviewer accounts, improperly influencing reviewers, or interfering with the confidentiality, independence, and integrity of the peer-review process.

  8. Ethical Violations: Conducting research involving human participants, identifiable personal data, human biological materials, or animals without the required ethical approval, informed consent, or other applicable safeguards.

  9. Data and Image Manipulation: Inappropriately altering, duplicating, fabricating, or selectively presenting research images, figures, tables, clinical findings, or other evidence in ways that misrepresent the underlying research.

  10. Undisclosed Conflicts of Interest: Failing to disclose financial, professional, personal, or institutional relationships that could improperly influence the research, its interpretation, or the publication process.

  11. Misrepresentation of Research: Providing false or misleading information about research methods, approvals, funding, trial registration, data availability, study results, or the qualifications and contributions of the research team.

  12. Other Serious Ethical Violations: Any other conduct that seriously undermines research integrity, participant safety, scientific reliability, or the fairness and transparency of scholarly publishing.

Honest errors, differences in scientific interpretation, or methodological disagreements do not automatically constitute research misconduct. Each case will be assessed based on the available evidence, its context, and applicable ethical standards.

2. Reporting Suspected Research Misconduct

MEDICA encourages authors, reviewers, editors, readers, research institutions, and other concerned parties to report suspected research misconduct. Allegations should be supported, where possible, by relevant evidence, such as manuscript excerpts, published articles, data records, images, correspondence, or other verifiable documentation.

Reports should be submitted to the journal's editorial office through its official communication channels. MEDICA will handle allegations responsibly, protect confidential information as far as reasonably possible, and take appropriate steps to prevent unnecessary harm to individuals involved.

Anonymous allegations may be considered when sufficient information is provided to permit a reasonable assessment. The journal will not automatically treat an allegation as proven merely because it has been reported.

3. Handling Allegations and Investigation Procedures

All allegations of research misconduct will be assessed objectively, fairly, and confidentially by the Editor-in-Chief and/or authorized members of the Editorial Board. Individuals with relevant conflicts of interest will be excluded from the assessment or decision-making process.

Depending on the nature and seriousness of the allegation, the journal may take the following steps:

  1. Initial Assessment: Review the allegation and available evidence to determine whether it falls within the scope of research or publication misconduct and whether further investigation is warranted.

  2. Evidence Examination: Examine the submitted manuscript, published article, similarity reports, research data, figures, ethical approval documentation, consent records, correspondence, or other relevant materials, as appropriate.

  3. Request for Explanation: Contact the corresponding author or relevant authors and provide an opportunity to explain the concerns and submit supporting documentation.

  4. Consultation with Experts: Seek advice from independent experts, reviewers, ethics specialists, or other qualified individuals when necessary, while managing potential conflicts of interest.

  5. Institutional Referral: Contact the authors' affiliated institution, research ethics committee, funder, or other relevant authority when the allegation is serious, the evidence requires institutional investigation, or the journal lacks the authority or resources to establish the facts independently.

  6. Editorial Decision: Assess the available evidence and determine the appropriate editorial action based on the findings and applicable publication ethics standards.

Authors will be given a reasonable opportunity to respond to allegations before an editorial decision is reached, except where immediate action is necessary to protect public health, research participants, or the integrity of the scholarly record. The journal will avoid making premature conclusions and will distinguish between an allegation, a concern under investigation, and a substantiated finding.

4. Possible Editorial Actions

Depending on the nature, severity, and findings of the case, MEDICA may take one or more of the following actions:

  • Request clarification, additional documentation, or a formal response from the authors.

  • Require correction of inaccurate, incomplete, or misleading information.

  • Return a manuscript for revision where the concerns can appropriately be resolved before publication.

  • Reject a manuscript when serious misconduct is established or the work fails to meet the journal's ethical requirements.

  • Suspend editorial processing while a significant concern is investigated.

  • Publish an Expression of Concern when there are substantial unresolved questions about a published article and readers need to be informed.

  • Publish a correction or retraction when required to maintain the accuracy and integrity of the scholarly record.

  • Notify the relevant institution, research ethics committee, funding agency, or other appropriate authority when warranted.

  • Restrict further editorial consideration of submissions from individuals involved in substantiated misconduct when justified, proportionate, and consistent with applicable policies.

Editorial actions will be proportionate to the established facts and will be documented appropriately. A retraction or other post-publication notice will be linked to the affected article and made publicly accessible where applicable.

5. Confidentiality and Fair Treatment

MEDICA will handle allegations with due regard for confidentiality, fairness, and the rights of all parties involved. Information will be shared only with individuals who need it for the assessment or investigation, subject to applicable legal, institutional, and ethical obligations.

The journal will seek to protect complainants, authors, reviewers, and other individuals from unnecessary disclosure and unfair treatment. However, absolute confidentiality cannot be guaranteed when disclosure is required for a fair investigation, legal compliance, or consultation with the relevant institution or authority.

All parties are expected to cooperate in good faith and provide accurate information. Knowingly submitting malicious or fabricated allegations may itself raise ethical concerns and will be assessed appropriately.

6. Research Involving Human Participants and Animals

For research involving human participants, patient information, identifiable personal data, human biological materials, or animals, authors must comply with applicable ethical standards and regulatory requirements. Where required, manuscripts must include information about approval from a recognized research ethics committee or institutional review board, informed consent, confidentiality protections, and relevant animal research approvals.

For clinical trials, authors must provide trial registration information when applicable and comply with relevant reporting and ethical requirements. MEDICA may request supporting documentation or contact the responsible ethics committee or institution if concerns arise regarding ethical approval, consent, participant safety, or research conduct.

Failure to obtain required approval or consent, or the provision of false ethical approval information, may result in rejection, an investigation, or post-publication action where appropriate.

7. Post-Publication Allegations

Allegations concerning articles that have already been published will be assessed with the same commitment to fairness, objectivity, and research integrity. MEDICA may review the available evidence, request explanations from the authors, consult independent experts, and contact relevant institutions when necessary.

If concerns remain unresolved but are sufficiently serious, the journal may publish an Expression of Concern. If substantial errors or misconduct are confirmed, MEDICA may issue a correction or retract the article, depending on the circumstances. The purpose of any post-publication action is to preserve the reliability, transparency, and accuracy of the scholarly record rather than to impose punishment without due process.

8. Appeals and Reconsideration

Authors who disagree with an editorial decision arising from a research misconduct investigation may submit a reasoned written appeal with relevant supporting evidence. Appeals will be reviewed by an editor or authorized representative who was not directly responsible for the original decision, where reasonably possible.

The journal may uphold, modify, or reconsider its decision based on the evidence and procedural fairness. An appeal does not automatically suspend necessary measures to protect the scholarly record or public interest.

9. Compliance with Publication Ethics Standards

MEDICA (International Medical Scientific Journal) follows the principles and relevant recommendations of the Committee on Publication Ethics (COPE) and other applicable research integrity and publication ethics standards in addressing suspected research misconduct.

The journal will apply these principles consistently, taking into account the nature of the allegation, the available evidence, the responsibilities of the parties involved, and the need to protect the integrity of the scholarly record.

By submitting a manuscript to MEDICA, authors acknowledge their responsibility to conduct and report research honestly, comply with relevant ethical requirements, disclose potential conflicts of interest, and cooperate with reasonable inquiries concerning the integrity of their work.